1-ethyl-2-benzimidazolinone has been researched along with 6-cyano-7-nitroquinoxaline-2,3-dione in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, N; Hu, H; Storm, JF; Vervaeke, K | 1 |
1 other study(ies) available for 1-ethyl-2-benzimidazolinone and 6-cyano-7-nitroquinoxaline-2,3-dione
| Article | Year |
|---|---|
SK (KCa2) channels do not control somatic excitability in CA1 pyramidal neurons but can be activated by dendritic excitatory synapses and regulate their impact.
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Animals; Anthracenes; Apamin; Benzimidazoles; Calcium Channel Agonists; Dendrites; Drug Interactions; Electric Stimulation; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Hippocampus; In Vitro Techniques; Male; Patch-Clamp Techniques; Potassium Channel Blockers; Pyramidal Cells; Rats; Rats, Wistar; Small-Conductance Calcium-Activated Potassium Channels; Synapses | 2008 |